No profile photo available

Mary C. Playdon, PhD, MPH

Languages spoken: English

Academic Information

Departments Adjunct - Population Health Sciences

Research Interests

  • Natural History of a Disease
  • Molecular Systematics

Research Statement

Dr. Playdon's research focuses on the role of modifiable lifestyle factors like diet and obesity in the development of cancer and survival after cancer diagnosis. With her collaborators, she has done cutting-edge research on developing dietary biomarkers using metabolomics to improve dietary measurement, and understand the mechanisms underlying dietary relationships with disease. Her research program at the University of Utah is further characterizing promising dietary biomarkers, exploring metabolic phenotype in the development of female and other diet-related cancers like colorectal cancer, and applying nutritional metabolomics to studies of cancer survivorship, including cohort studies and dietary interventions.

Cancer patients, and the public, have a strong interest in what dietary factors might prevent cancer or improve survival after cancer diagnosis. Many questions remain, since dietary measurement is prone to errors that can make it difficult to detect diet-cancer signals. Dr. Playdon's recent work validating dietary biomarkers has uncovered several markers with potential to be considered 'gold standard' that could be used to improve the measurement of diet. She also uncovered the trove of information available by measuring metabolites from a small blood sample: what a person ate, how that food might have been processed and prepared, and how their metabolism has responded to diet. Since many large observational studies have thousands or tens of thousands of patient samples in storage, nutritional metabolomics could be conducted with immediate effect and applied to studies of diseases like cancer on a very large-scale. This has the potential to dramatically shift the landscape of nutritional research.

Many cancer survivors, particularly survivors of obesity-related cancers, are at high risk of developing comorbidities after cancer diagnosis, including diabetes and cardiovascular disease. Dr. Playdon is developing studies to explore the etiology of metabolic abnormalities and comorbidities among cancer patients using molecular epidemiology approaches. Furthermore, she is studying strategies to improve metabolic health among cancer patients including modifying dietary pattern, meal timing, and lifestyle interventions that include combinations of diet and physical activity.

Having counseled hundreds of women that are living with a diagnosis of cancer on diet and lifestyle change as a research dietitian continues to inspire Dr. Playdon's passion for making discoveries related to the role of nutrition in both preventing cancer, and prolonging life and improving the quality of life of cancer survivors.

Education History

Postdoctoral Fellowship National Cancer Institute
 Postdoctoral Fellow
Doctoral Training Yale School of Public Health
 PhD
Graduate Training Yale School of Public Health
 MPhil
Graduate Training Queensland University of Technology
 MPH
Undergraduate Queensland University of Technology
 BSc

Selected Publications

Journal Article

  1. Liu L, Kazemian E, Loroa NC, Shirazipour C, Gong J, Crowder SL, Nguyen N, Damerell V, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Hardikar S, Siegel EM, Bower JE, Gigic B, Hoogland AI, Li X, Small BJ, Kaufman H, Jim HSL, Figueiredo JC (2026). Longitudinal Study on the Influence of Physical Activity in Managing Fatigue in Patients With Colorectal Cancer. J Natl Compr Canc Netw, 1-8.
  2. Hoobler R, Tabung FK, Lin T, Gigic B, Smith KS, Woodruff K, Crowder SL, Hardikar S, Byrd DA, Coletta AM, Sanchez A, Chaix A, Greathouse KL, Ilozumba MN, Ose J, Damerell V, Strehli I, McLaws M, Florou V, Huang LC, Shibata D, Figueiredo JC, Toriola AT, Li CI, Ulrich CM, Playdon MC (2026). Dietary Patterns Associated With Weight Loss Among Patients With Colorectal Cancer During the First 6 Months After Diagnosis: A Cross-Sectional Analysis From the ColoCare Study. J Acad Nutr Diet, 126(8), 156351.
  3. Malcomson FC, Lee SK, OConnell CP, Shams-White MM, Reedy J, Playdon MC, Tabung FK, Watts EL, Moore SC, Hong HG, Loftfield E (2026). Multi-metabolite Scores of Alignment with the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations in the Interactive Diet and Activity Tracking in AARP Study. J Nutr, 156(8), 101605.
  4. Hoobler R, Maschek JA, Luo B, Murphy EA, Kubinak JL, Stewart PA, Cox JE, Chaix A, Woodruff K, Sanchez A, Coletta AM, Tabung FK, Gupta S, Hardikar S, Colman H, Playdon MC (2026). Identification of Circulating Lipidomic Biomarkers of Malnutrition Risk among Oncology Patients in the Total Cancer Care (TCC) Study: A Cross-Sectional Analysis. J Nutr, 156(7), 101603.
  5. Loroa NC, Liu L, Kazemian E, Acuna N, Playdon MC, Cubitt CL, Kabir S, Crowder SL, Nguyen N, Gomez M, Damerell V, Mooney K, Erickson PA, Ilozumba M, Himbert C, Siegel E, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Hardikar S, Byrd DA, Bower JE, Hoogland AI, Li X, Small BJ, Gigic B, Jim HSL, Figueiredo JC (2026). Longitudinal Associations Between Inflammatory Biomarkers and Fatigue in Patients With Colorectal Cancer: A Multicenter Study. Cancer Med, 15(7), e72135.
  6. Zhang T, Moore SC, Fu S, Albanes D, Liao LM, Loftfield E, Playdon MC, Weinstein SJ, Yu K, Stolzenberg-Solomon RZ (2026). Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk. Am J Epidemiol, 195(6), 1572-1584.
  7. Hoobler R, Puklin LS, Harrigan M, Cartmel B, Li FY, Sanft T, Ferrucci LM, Irwin ML, Playdon MC (2024). Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study. J Cancer Surviv, 20(3), 990-998.
  8. Maslana KE, Burns RD, Bai Y, Playdon MC, Estabrooks PA, Saviers-Steiger C, Dunston ER, Galyean P, Kimball ER, Zickmund SL, Hansen PA, Ulrich CM, LaStayo PC, Steinberg D, Noren CS, Finch A, Seckinger L, Oza S, Brownson KE, Coletta AM (2026). The association of an exercise and rehabilitation clinical workflow algorithm on sedentary behavior and performance status from time of breast cancer diagnosis and throughout care. Breast Cancer Res Treat, 217(2).
  9. Winn M, Pauleck S, Richardson S, Viskochil R, Karra P, Colman H, Doherty JA, Xu Y, Hu-Lieskovan S, Litchman M, Playdon MC, Hardikar S (2025). New-onset prediabetes/diabetes worsens overall survival in patients with cancer: A real-world retrospective cohort study. Diabetes Obes Metab, 28(2), 1247-1257.
  10. Hebert JR, Murphy EA, Playdon MC, Makowski L, Ibele AR, Fairman CM, Hofseth LJ (2025). Are GLP-1 receptor agonists a 'magic bullet' for cancer? Nat Rev Cancer, 26(1), 3-4.
  11. Shi N, Hoobler R, Harewood R, Toland AE, Albanes D, Bouras E, Gunter MJ, Liao LM, Moore SC, Ricceri F, Rotter JI, Sinha R, Stolzenberg-Solomon R, Tjnneland A, Wood AC, Yu D, Playdon MC, Tabung FK (2025). Insulinemic and inflammatory dietary patterns and colorectal cancer risk: a dietary data harmonization study of one million participants in the Consortium of Metabolomics Studies (COMETS). Am J Clin Nutr, 123(1), 101099.
  12. Wang X, Xia P, Wang F, Wu Z, Hu Y, Eliassen AH, Zeleznik OA, Bhupathiraju SN, Mousavi SM, Prentice RL, Tinker LF, Zheng C, Liu S, Huang Y, Navarro SL, Playdon MC, Moore SC, Snetselaar L, Tabung FK, Manson JE, Qi L, Raftery D, Willett WC, Lampe JW, Neuhouser ML, Sun Q (2026). Metabolomic signatures of dietary carbohydrates and differential association with type 2 diabetes. Nat Health, 1(1), 145-157.
  13. Kazemian E, Mo Q, Matejcic M, Tsai YY, Sobieski D, Li X, Hoogland AI, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Loroa NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Hardikar S, Kahlert C, Siegel EM, Bower JE, Schmit SL, Gigic B, Jim HSL, Figueiredo JC (2025). Genetic predisposition to persistent fatigue after a diagnosis of colorectal cancer. J Natl Cancer Inst, 117(12), 2513-2525.
  14. Hoobler R, Herrera M, Woodruff K, Sanchez A, Coletta AM, Chaix A, Elizondo J, Playdon MC (2025). Malnutrition Risk Is Associated With All-Cause Mortality and Chemotherapy Complications Among Adults Diagnosed With Diverse Cancer Types: A Retrospective Cohort Study. J Acad Nutr Diet, 125(9), 1242-1255.e10.
  15. Maslana KE, Burns RD, Estabrooks PA, Playdon MC, Shaw JM, Akerley W, Coletta AM (2025). Association between physical activity, performance scores, and clinical trial enrollment in cancer survivors. BMC Cancer, 25(1), 1377.
  16. Snyder AM, Stone CJ, Ufkes N, Greene T, Playdon MC, Murtaugh MA, Vanneman ME, Secrest AM (2024). Lifestyle, medication use, and age considerations with acne vulgaris: A prospective study. JEADV Clin Pract, 4(1), 82-94.
  17. Karra P, Hardikar S, Winn M, Anderson GL, Haaland B, Shadyab AH, Neuhouser ML, Seguin-Fowler RA, Thomson CA, Coday M, Wactawski-Wende J, Stefanick ML, Zhang X, Cheng TD, Karanth S, Sun Y, Saquib N, Pichardo MS, Jung SY, Tabung FK, Summers SA, Holland WL, Jalili T, Gunter MJ, Playdon MC (2024). Metabolic Phenotype and Risk of Obesity-Related Cancers in the Women's Health Initiative. Cancer Prev Res (Phila), 18(2), 63-72.
  18. Shi N, Nepal S, Hoobler R, Menni C, Playdon MC, Spakowicz D, Wells PM, Steves CJ, Clinton SK, Tabung FK (2024). Pro-inflammatory and hyperinsulinaemic dietary patterns are associated with specific gut microbiome profiles: a TwinsUK cohort study. Gut Microbiome (Camb), 5, e12.
  19. Smith KS, Gudenkauf LM, Hoogland AI, Li X, Hoobler R, Playdon MC, Gigic B, Small BJ, Gonzalez BD, Oswald LB, Byrd DA, Greathouse KL, Ulrich CM, Li CI, Shibata D, Toriola AT, Peoples AR, Siegel EM, Figueiredo JC, Jim HSL, Crowder SL (2024). Associations Between Dietary Patterns and Quality of Life in a Longitudinal Cohort of Colorectal Cancer Survivors. Nutrients, 16(22).
  20. Huybrechts I, Chimera B, Hanley-Cook GT, Biessy C, Deschasaux-Tanguy M, Touvier M, Kesse-Guyot E, Srour B, Baudry J, Berlivet J, Casagrande C, Nicolas G, Lopez JB, Millett CJ, Cakmak EK, Robinson OJK, Murray KA, Schulze MB, Masala G, Guevara M, Bodn S, Cross AJ, Tsilidis K, Heath AK, Panico S, Amiano P, Huerta JM, Key T, Ericson U, Stocks T, Lundblad MW, Skeie G, Sacerdote C, Katzke V, Playdon MC, Ferrari P, Vineis P, Lachat C, Gunter MJ (2024). Food biodiversity and gastrointestinal cancer risk in nine European countries: Analysis within a prospective cohort study. Eur J Cancer, 210, 114258.
  21. Fitzgerald VK, Lutsiv T, McGinley JN, Neil ES, Playdon MC, Thompson HJ (2024). Common Bean Suppresses Hepatic Ceramide Metabolism in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease. Nutrients, 16(18).
  22. McCullough ML, Masters M, Hartman TJ, Flanders WD, Playdon MC, Elahy V, Hodge RA, Teras LR, Wang Y, Patel AV (2024). Length of Overnight Fasting and 6-year Weight Change in the Cancer Prevention Study-3. J Nutr, 154(9), 2834-2842.
  23. Crowder SL, Li X, Himbert C, Viskochil R, Hoogland AI, Gudenkauf LM, Oswald LB, Gonzalez BD, Small BJ, Ulrich CM, Ose J, Peoples AR, Li CI, Shibata D, Toriola AT, Gigic B, Playdon MC, Hardikar S, Bower J, Siegel EM, Figueiredo JC, Jim HSL (2024). Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study. Ann Behav Med, 58(3), 156-166.
  24. Playdon MC, Tinker LF, Prentice RL, Loftfield E, Hayden KM, Van Horn L, Sampson JN, Stolzenberg-Solomon R, Lampe JW, Neuhouser ML, Moore SC (2023). Measuring diet by metabolomics: a 14-d controlled feeding study of weighed food intake. Am J Clin Nutr, 119(2), 511-526.
  25. Li Y, Chaurasia B, Rahman MM, Kaddai V, Maschek JA, Berg JA, Wilkerson JL, Mahmassani ZS, Cox J, Wei P, Meikle PJ, Atkinson D, Wang L, Poss AM, Playdon MC, Tippetts TS, Mousa EM, Nittayaboon K, Anandh Babu PV, Drummond MJ, Clevers H, Shayman JA, Hirabayashi Y, Holland WL, Rutter J, Edgar BA, Summers SA (2023). Ceramides Increase Fatty Acid Utilization in Intestinal Progenitors to Enhance Stemness and Increase Tumor Risk. Gastroenterology, 165(5), 1136-1150.
  26. Karra P, Hardikar S, Winn M, Anderson GL, Haaland B, Krick B, Thomson CA, Shadyab A, Luo J, Saquib N, Strickler HD, Chlebowski R, Arthur RS, Summers SA, Holland WL, Jalili T, Playdon MC (2023). New-Onset Diabetes after an Obesity-Related Cancer Diagnosis and Survival Outcomes in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev, 32(10), 1356-1364.
  27. Li X, Hoogland AI, Small BJ, Crowder SL, Gonzalez BD, Oswald LB, Sleight AG, Nguyen N, Lorona NC, Damerell V, Komrokji KR, Mooney K, Playdon MC, Ulrich CM, Li CI, Shibata D, Toriola AT, Ose J, Peoples AR, Siegel EM, Bower JE, Schneider M, Gigic B, Figueiredo JC, Jim HSL (2023). Trajectories and risk factors of fatigue following colorectal cancer diagnosis. Colorectal Dis, 25(10), 2054-2063.
  28. Rhee J, Loftfield E, Albanes D, Layne TM, Stolzenberg-Solomon R, Liao LM, Playdon MC, Berndt SI, Sampson JN, Freedman ND, Moore SC, Purdue MP (2023). A metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate. Environ Int, 180, 108198.
  29. Winn M, Karra P, Freisling H, Gunter MJ, Haaland B, Litchman ML, Doherty JA, Playdon MC, Hardikar S (2023). Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination Survey. Endocrinol Diabetes Metab, 6(4), e433.
  30. Lim J, Hong HG, Weinstein SJ, Playdon MC, Cross AJ, Stolzenberg-Solomon R, Freedman ND, Huang J, Albanes D (2023). Metabolomic Analysis of Vitamin E Supplement Use in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Nutrients, 15(13).
  31. Peterson L, Lee H, Huybrechts I, Biessy C, Neuhouser ML, Haaland B, Krick B, Gunter M, Schulze MB, Jannasch F, Coletta AM, Hardikar S, Chaix A, Bauer CX, Xiao Q, Playdon MC (2023). Reliability estimates for assessing meal timing derived from longitudinal repeated 24-hour dietary recalls. Am J Clin Nutr, 117(5), 964-975.
  32. Romanos-Nanclares A, Tabung FK, Sinnott JA, Trabert B, De Vivo I, Playdon MC, Eliassen AH (2022). Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women. J Natl Cancer Inst, 115(3), 311-321.
  33. Winn M, Karra P, Haaland B, Doherty JA, Summers SA, Litchman ML, Gunter MJ, Playdon MC, Hardikar S (2022). Metabolic dysfunction and obesity-related cancer: Results from the cross-sectional National Health and Nutrition Examination Survey. Cancer Med, 12(1), 606-618.
  34. Crowder SL, Welniak TL, Hoogland AI, Small BJ, Rodriguez Y, Carpenter KM, Fischer SM, Li D, Kinney AY, Rotroff D, Mariam A, Brownstein N, Reich RR, Hembree T, Playdon MC, Arthur AE, Vieytes CA, Li Z, Extermann M, Kim R, Berry DL, Jim HSL (2022). Diet quality indices and changes in cognition during chemotherapy. Support Care Cancer, 31(1), 75.
  35. Sharma A, Krick B, Li Y, Summers SA, Playdon MC, Welt C (2022). The Use of Ceramides to Predict Metabolic Response to Metformin in Women With PCOS. J Endocr Soc, 6(11), bvac131.
  36. Poss AM, Krick B, Maschek JA, Haaland B, Cox JE, Karra P, Ibele AR, Hunt SC, Adams TD, Holland WL, Playdon MC, Summers SA (2022). Following Roux-en-Y gastric bypass surgery, serum ceramides demarcate patients that will fail to achieve normoglycemia and diabetes remission. Med, 3(7), 452-467.e4.
  37. Kliemann N, Ould Ammar R, Biessy C, Gicquiau A, Katzke V, Kaaks R, Tjnneland A, Olsen A, Snchez MJ, Crous-Bou M, Pasanisi F, Tin Tin S, Perez-Cornago A, Aune D, Christakoudi S, Heath AK, Colorado-Yohar SM, Grioni S, Skeie G, Sartor H, Idahl A, Rylander C, May AM, Weiderpass E, Freisling H, Playdon MC, Rinaldi S, Murphy N, Huybrechts I, Dossus L, Gunter MJ (2022). Metabolically Defined Body Size Phenotypes and Risk of Endometrial Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev, 31(7), 1359-1367.
  38. Thompson HJ, Levitt JO, McGinley JN, Chandler P, Guenther PM, Huybrechts I, Playdon MC (2021). Measuring Dietary Botanical Diversity as a Proxy for Phytochemical Exposure. Nutrients, 13(4).
  39. Xiao Q, Bauer C, Layne T, Playdon M (2021). The association between overnight fasting and body mass index in older adults: the interaction between duration and timing. Int J Obes (Lond), 45(3), 555-564.
  40. Moore SC, Mazzilli KM, Sampson JN, Matthews CE, Carter BD, Playdon MC, Wang Y, Stevens VL (2021). A Metabolomics Analysis of Postmenopausal Breast Cancer Risk in the Cancer Prevention Study II. Metabolites, 11(2).
  41. Evans AM, ODonovan C, Playdon M, Beecher C, Beger RD, Bowden JA, Broadhurst D, Clish CB, Dasari S, Dunn WB, Griffin JL, Hartung T, Hsu PC, Huan T, Jans J, Jones CM, Kachman M, Kleensang A, Lewis MR, Monge ME, Mosley JD, Taylor E, Tayyari F, Theodoridis G, Torta F, Ubhi BK, Vuckovic D (2020). Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC–MS based untargeted metabolomics practitioners. Int J Obes (Lond), 16(10), 113.
  42. Kiblawi R, Holowatyj AN, Gigic B, Brezina S, Geijsen AJMR, Ose J, Lin T, Hardikar S, Himbert C, Warby CA, Bhm J, Bours MJL, Van Duijnhoven FJB, Gumpenberger T, Kok DE, Koole JL, Van Roekel EH, Schrotz-King P, Ulvik A, Gsur A, Habermann N, Weijenberg MP, Ueland PM, Schneider M, Ulrich A, Ulrich CM, Playdon M (2020). One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: Results from the ColoCare Study. Br J Nutr, 123(10), 1187-1200.
  43. Hardikar S, Albrechtsen RD, Achaintre D, Lin T, Pauleck S, Playdon M, Holowatyj AN, Gigic B, Schrotz-King P, Boehm J, Habermann N, Brezina S, Gsur A, van Roekel EH, Weijenberg MP, Keski-Rahkonen P, Scalbert A, Ose J, Ulrich CM (2020). Impact of pre-blood collection factors on plasma metabolomic profiles. Br J Nutr, 10(5).
  44. Poss AM, Maschek JA, Cox JE, Hauner BJ, Hopkins PN, Hunt SC, Holland WL, Summers SA, Playdon MC (2019). Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease. J Clin Invest, 130(3), 1363-1376.
  45. Kiblawi R Holowatyj AN Gigic B Brezina S Geijsen AJMR Ose J Lin T Hardikar S Himbert C Warby CA Bhm J Bours MJL van Duijnhoven FJB Gumpenberger T Kok DE Koole JL van Roekel EH Schrotz-King P Ulvik A Gsur A Habermann N Weijenberg MP U (02/01/2020). One-carbon metabolites, B-vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study. Br J Nutr, 123(10), 1-32.
  46. Kim S, Park J, Chen Y, Rowe K, Snyder J, Fraser A, Smith K, Deshmukh VG, Newman M, Herget K, Porucznik CA, Ose D, Playdon M, Gaffney D, Hashibe M (2020). Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. Br J Nutr, 156(1), 185-193.
  47. Maruvada P Lampe JW Wishart DS Barupal D Chester DN Dodd D Djoumbou-Feunang Y Dorrestein PC Dragsted LO Draper J Duffy LC Dwyer JT Emenaker NJ Fiehn O Gerszten RE B Hu F Karp RW Klurfeld DM Laughlin MR Little AR Lynch CJ Moore SC Nicas (10/01/2019). Perspective: Dietary Biomarkers of Intake and Exposure—Exploration with Omics Approaches.
  48. Playdon MC, Joshi AD, Tabung FK, Cheng S, Henglin M, Kim A, Lin T, van Roekel EH, Huang J, Krumsiek J, Wang Y, Math E, Temprosa M, Moore S, Chawes B, Eliassen AH, Gsur A, Gunter MJ, Harada S, Langenberg C, Oresic M, Perng W, Seow WJ, Zeleznik OA (2019). Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS). Metabolites, 9(7).
  49. Murphy RA, Moore S, Playdon M, Kritchevsky S, Newman AB, Satterfield S, Ayonayon H, Clish C, Gerszten R, Harris TB (2019). Metabolites associated with risk of developing mobility disability in the health, aging and body composition study. Br J Nutr, 74(1), 73-80.
  50. Beger RD, Dunn WB, Bandukwala A, Bethan B, Broadhurst D, Clish CB, Dasari S, Derr L, Evans A, Fischer S, Flynn T, Hartung T, Herrington D, Higashi R, Hsu PC, Jones C, Kachman M, Karuso H, Kruppa G, Lippa K, Maruvada P, Mosley J, Ntai I, ODonovan C, Playdon M, Raftery D, Shaughnessy D, Souza A, Spaeder T, Spalholz B, Tayyari F, Ubhi B, Verma M, Walk T, Wilson I, Witkin K, Bearden DW, Zanetti KA (2019). Towards quality assurance and quality control in untargeted metabolomics studies. Br J Nutr, 15(1).

Review

  1. Raji LM, Siddique MM, Bohm MS, Pierre JF, Playdon MC, Summers SA, Li B, Cook KL, Murphy EA, Makowski L (2024). Murine Models of Obesity-Related Cancer Risk. [Review]. Cancer Prev Res (Phila), 18(9), 509-529.
  2. Landberg R, Karra P, Hoobler R, Loftfield E, Huybrechts I, Rattner JI, Noerman S, Claeys L, Neveu V, Vidkjaer NH, Savolainen O, Playdon MC, Scalbert A (2024). Dietary biomarkers-an update on their validity and applicability in epidemiological studies. [Review]. Nutr Rev, 82(9), 1260-1280.
  3. Giles ED, Purcell SA, Olson J, Vrieling A, Hirko KA, Woodruff K, Playdon MC, Thomas GA, Gilmore LA, Moberly HK, Newell-Fugate AE (2023). Trends in Diet and Cancer Research: A Bibliometric and Visualization Analysis. [Review]. Cancers (Basel), 15(15).
  4. Thompson HJ, Lutsiv T, McGinley JN, Hussan H, Playdon MC (2023). Dietary Oncopharmacognosy as a Crosswalk between Precision Oncology and Precision Nutrition. [Review]. Nutrients, 15(9).
  5. Playdon MC, Hardikar S, Karra P, Hoobler R, Ibele AR, Cook KL, Kumar A, Ippolito JE, Brown JC (2022). Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities. [Review]. J Natl Cancer Inst Monogr, 2023(61), 68-76.
  6. Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A, Doherty J, Ulrich CM, Summers SA, Gunter M, Hardikar S, Playdon MC (2022). Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. [Review]. Obesity (Silver Spring), 30(7), 1323-1334.
  7. Sleight AG, Crowder SL, Skarbinski J, Coen P, Parker NH, Hoogland AI, Gonzalez BD, Playdon MC, Cole S, Ose J, Murayama Y, Siegel EM, Figueiredo JC, Jim HSL (2022). A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care. [Review]. Cancers (Basel), 14(8).
  8. Crowder SL, Playdon MC, Gudenkauf LM, Ose J, Gigic B, Greathouse L, Peoples AR, Sleight AG, Jim HSL, Figueiredo JC (2022). A Molecular Approach to Understanding the Role of Diet in Cancer-Related Fatigue: Challenges and Future Opportunities. [Review]. Nutrients, 14(7).
  9. Veettil SK, Wong TY, Loo YS, Playdon MC, Lai NM, Giovannucci EL, Chaiyakunapruk N (2021). Role of Diet in Colorectal Cancer Incidence: Umbrella Review of Meta-analyses of Prospective Observational Studies. [Review]. JAMA Netw Open, 4(2), e2037341.
  10. Maruvada P, Lampe JW, Wishart DS, Barupal D, Chester DN, Dodd D, Djoumbou-Feunang Y, Dorrestein PC, Dragsted LO, Draper J, Duffy LC, Dwyer JT, Emenaker NJ, Fiehn O, Gerszten RE, B Hu F, Karp RW, Klurfeld DM, Laughlin MR, Little AR, Lynch CJ, Moore SC, Nicastro HL, OBrien DM, Ordovs JM, Osganian SK, Playdon M, Prentice R, Raftery D, Reisdorph N, Roche HM, Ross SA, Sang S, Scalbert A, Srinivas PR, Zeisel SH (2020). Perspective: Dietary Biomarkers of Intake and Exposure - Exploration with Omics Approaches. [Review]. Br J Nutr, 11(2), 200-215.
  11. McGee EE, Kiblawi R, Playdon MC, Eliassen AH (2019). Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions. [Review]. Curr Nutr Rep, 8(3), 187-201.
  12. Playdon M, Thomas G, Sanft T, Harrigan M, Ligibel J, Irwin M (2013). Weight loss intervention for breast cancer survivors: A systematic review. [Review]. Br J Nutr, 5(3), 222-246.

Letter

  1. Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML (2016). Response [Letter to the editor]. Br J Nutr, 108(4).

Other

  1. Shu X, Chen Z, Long J, Guo X, Yang Y, Qu C, Ahn YO, Cai Q, Casey G, Gruber SB, Huyghe JR, Jee SH, Jenkins MA, Jia WH, Jung KJ, Kamatani Y, Kim DH, Kim J, Kweon SS, Le Marchand L, Matsuda K, Matsuo K, Newcomb PA, Oh JH, Ose J, Oze I, Pai RK, Pan ZZ, Pharoah PDP, Playdon MC, Ren ZF, Schoen RE, Shin A, Shin MH, Shu XO, Sun X, Tangen CM, Tanikawa C, Ulrich CM, van Duijnhoven FJB, Van Guelpen B, Wolk A, Woods MO, Wu AH, Peters U, Zheng W (2021). Large-scale Integrated Analysis of Genetics and Metabolomic Data Reveals Potential Links Between Lipids and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev (31(6), pp. 1216-1226). United States.
  2. Xiao Q, Matthews CE, Playdon M, Bauer C (2021). The association between rest-activity rhythms and glycemic markers: the US National Health and Nutrition Examination Survey, 2011-2014. Sleep (45(2)). United States.
  3. Coletta AM, Playdon MC, Baron KG, Wei M, Kelley K, Vaklavas C, Beck A, Buys SS, Chipman J, Ulrich CM, Walker D, White S, Oza S, Zingg RW, Hansen PA (2021). The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors. PLoS One (16(10), pp. e0258135). United States.
  4. Nicholson RJ, Poss AM, Maschek JA, Cox JE, Hopkins PN, Hunt SC, Playdon MC, Holland WL, Summers SA (2020). Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study. J Clin Endocrinol Metab (106(8), pp. e3098-e3109). United States.
  5. Qi J, Spinelli JJ, Dummer TJB, Bhatti P, Playdon MC, Levitt JO, Hauner B, Moore SC, Murphy RA (2021). Metabolomics and cancer preventive behaviors in the BC Generations Project. Sci Rep (11(1), p. 12094). England.
  6. Mazzilli KM, McClain KM, Lipworth L, Playdon MC, Sampson JN, Clish CB, Gerszten RE, Freedman ND, Moore SC (2019). Identification of 102 Correlations between Serum Metabolites and Habitual Diet in a Metabolomics Study of the Prostate, Lung, Colorectal, and Ovarian Cancer Trial. J Nutr (150(4), pp. 694-703). United States.
  7. McGee EE, Kiblawi R, Playdon MC, Eliassen AH (2019). Correction to: Nutritional Metabolomics in Cancer Epidemiology: Current Trends, Challenges, and Future Directions. Curr Nutr Rep (8(3), p. 202). United States.
  8. Yu B, Zanetti KA, Temprosa M, Albanes D, Appel N, Barrera CB, Ben-Shlomo Y, Boerwinkle E, Casas JP, Clish C, Dale C, Dehghan A, Derkach A, Eliassen AH, Elliott P, Fahy E, Gieger C, Gunter MJ, Harada S, Harris T, Herr DR, Herrington D, Hirschhorn JN, Hoover E, Hsing AW, Johansson M, Kelly RS, Khoo CM, Kivimki M, Kristal BS, Langenberg C, Lasky-Su J, Lawlor DA, Lotta LA, Mangino M, Le Marchand L, Math E, Matthews CE, Menni C, Mucci LA, Murphy R, Oresic M, Orwoll E, Ose J, Pereira AC, Playdon MC, Poston L, Price J, Qi Q, Rexrode K, Risch A, Sampson J, Seow WJ, Sesso HD, Shah SH, Shu XO, Smith GCS, Sovio U, Stevens VL, Stolzenberg-Solomon R, Takebayashi T, Tillin T, Travis R, Tzoulaki I, Ulrich CM, Vasan RS, Verma M, Wang Y, Wareham NJ, Wong A, Younes N, Zhao H, Zheng W, Moore SC (2018). The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies. Am J Epidemiol (188(6), pp. 991-1012). United States.